First 24–48 hours
- — Crash: exhaustion
- — hypersomnia
- — increased appetite
- — severe dysphoria
Adderall is a prescription amphetamine for attention-deficit / hyperactivity disorder (ADHD) and narcolepsy — and one of the most commonly misused prescription stimulants in the U.S.
Adderall is a prescription amphetamine for attention-deficit / hyperactivity disorder (ADHD) and narcolepsy — and one of the most commonly misused prescription stimulants in the U.S. Misuse spans students using it as a study aid, professionals using it for performance, and patients who started with a legitimate prescription and escalated. Long-term misuse drives stimulant use disorder, cardiac strain, sleep collapse, and significant psychiatric harm. Treatment combines behavioral care, integrated ADHD evaluation, and — when clinically appropriate — non-stimulant medication strategies.
Also known as: Adderall, amphetamine, amphetamine salts, speed, study drug.
Every person's experience varies. The windows below describe typical clinical patterns — your care team adjusts the plan based on how you respond.
Adderall withdrawal is rarely life-threatening but cardiovascular monitoring is important, especially after high-dose or long-duration use. Medical detox supports a safe transition off the medication.
Many Adderall-misusing patients have undiagnosed or undertreated ADHD. A clinical evaluation determines whether non-stimulant ADHD medications (atomoxetine, guanfacine, bupropion) are clinically appropriate — and helps differentiate ADHD from stimulant-driven attention problems.
CBT addresses the specific triggers driving misuse — academic stress, performance anxiety, executive-function gaps — and builds non-stimulant coping strategies.
Contingency management is the most effective behavioral treatment for stimulant use disorder, including amphetamine-type stimulants like Adderall.
PHP, IOP, and outpatient maintain clinical contact through the extended post-acute window when relapse risk peaks under academic or workplace stress.
Adderall misuse is widespread on Kentucky college campuses and in white-collar workplaces, often beginning with a legitimate prescription or borrowed pills before escalating. Kentucky's prescribing patterns and pill-mill history make the state's risk profile higher than the national average. Louisville's universities and large employers feed steady demand for stimulant-use treatment.
Kentucky Medicaid plans typically cover residential, PHP, IOP, and outpatient SUD services for stimulant use disorder, including Adderall misuse. Coverage also includes psychiatric evaluation and non-stimulant ADHD medications when clinically appropriate.
Coverage is determined by medical necessity using ASAM criteria. Our admissions team verifies your specific plan during your first call.
Yes. Stimulant use disorder is defined by patterns of use, not by whether the medication was originally prescribed. Many patients with stimulant use disorder started with a legitimate prescription. Reframing the conversation as a clinical issue — rather than a moral one — is the first step in treatment.
Not necessarily. A clinical evaluation determines whether stimulants can be continued safely at a therapeutic dose, whether non-stimulant ADHD medications (atomoxetine, bupropion) are a better fit, or whether a stimulant-free path is clinically appropriate. The decision is made with you, not handed down.
Many Adderall-misusing patients do have ADHD that was never formally diagnosed. Our integrated psychiatric care includes ADHD evaluation as part of the assessment and treatment plan.
Kentucky Medicaid plans typically cover residential, PHP, IOP, and outpatient SUD services for stimulant use disorder, plus psychiatric evaluation and non-stimulant ADHD medications based on medical-necessity determinations.
24/7 admissions. Insurance verification in minutes. Most KY Medicaid plans accepted. No judgment, no pressure, no obligation.